Well also discuss safety considerations, clinical research, and training resources such as Peptide Training for those who wish to deepen their expertise
Redemplo (plozasiran): Plozasiran, an RNA interference therapeutic, reduces apoC-III production, impacting triglyceride metabolism in familial chylomicronemia syndrome (FCS) patients
Because the peptide remains highly stable in gastric environments, it has become a preferred compound for researchers examining gut-related biological processes and tissue recovery mechanisms
Such an approach illustrates the utility of HDX-MS for mapping PPIs and its potential for elucidating the interactions between excipients and proteins, which would have direct applicability to developability considerations and formulation composition design
Kerimi, A., & Williamson, G